Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Visum Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end generic and innovative medicines. The company focuses on key therapeutic areas including ophthalmology, the central nervous system (CNS), and cardiovascular diseases. Visum operates large-scale, GMP-certified manufacturing facilities in Haikou and maintains advanced R&D centers in Beijing and Shanghai. Their business strategy combines the development of complex formulations and 505(b)(2) products with a growing pipeline of biosimilars and innovative drugs. Additionally, Visum provides comprehensive CDMO services to global pharmaceutical partners, leveraging its expertise in drug delivery systems and high-quality production standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Visum.